153 related articles for article (PubMed ID: 37242249)
1. Effect of Inhibiting Butyrylcholinesterase Activity Using Fractionated Coffee Extracts Digested In Vitro in Gastrointestinal Tract: Docking Simulation and Calorimetric and Studies.
Grzelczyk J; Szwajgier D; Baranowska-Wójcik E; Pérez-Sánchez H; Carmena-Bargueño M; Sosnowska B; Budryn G
Nutrients; 2023 May; 15(10):. PubMed ID: 37242249
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of butyrylcholinesterase inhibitory activity by chlorogenic acids and coffee extracts assed in ITC and docking simulation models.
Budryn G; Grzelczyk J; Jaśkiewicz A; Żyżelewicz D; Pérez-Sánchez H; Cerón-Carrasco JP
Food Res Int; 2018 Jul; 109():268-277. PubMed ID: 29803450
[TBL] [Abstract][Full Text] [Related]
3. BChE inhibitors from marine organisms - A review.
Lins Alves LK; Cechinel Filho V; de Souza RLR; Furtado-Alle L
Chem Biol Interact; 2022 Nov; 367():110136. PubMed ID: 36096160
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
Jasiecki J; Wasąg B
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
[No Abstract] [Full Text] [Related]
5. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
6. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
[TBL] [Abstract][Full Text] [Related]
8. Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.
Lu T; Liu Y; Liu Y; Chen H; Han C; Feng X; Zhou H; Li Y
Future Med Chem; 2021 May; 13(9):769-784. PubMed ID: 33759552
[No Abstract] [Full Text] [Related]
9. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
11. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors.
Ozturk O; Farouk FM; Ooi L; Law CSW; Muhammed MT; Aki-Yalcin E; Yeong KY
Mol Divers; 2022 Oct; 26(5):2863-2876. PubMed ID: 35780204
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
[TBL] [Abstract][Full Text] [Related]
14. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
15. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
17. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.
Baumann K; Kordić L; Močibob M; Šinko G; Tomić S
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382668
[TBL] [Abstract][Full Text] [Related]
19. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies.
Budryn G; Majak I; Grzelczyk J; Szwajgier D; Rodríguez-Martínez A; Pérez-Sánchez H
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745206
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
